We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

85 hedge funds and large institutions have $111M invested in Eledon Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 15

4% more ownership

Funds ownership: 64.21% → 68.21% (+4%)

2% more funds holding

Funds holding: 83 → 85 (+2)

8% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 26

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less capital invested

Capital invested by funds: $130M → $111M (-$19.7M)

40% less call options, than puts

Call options by funds: $134K | Put options by funds: $223K

Holders
85
Holders Change
+2
Holders Change %
+2.41%
% of All Funds
1.12%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
21
Reduced
15
Closed
26
Calls
$134K
Puts
$223K
Net Calls
-$89K
Net Calls Change
+$157K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.81M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.15M
3
State Street
State Street
Massachusetts
+$1.18M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.1M
5
Northern Trust
Northern Trust
Illinois
+$970K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.92M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.7M
3
BOCH
Blue Owl Capital Holdings
New York
-$1.47M
4
SFM
Sphera Funds Management
Israel
-$1.04M
5
SSA
Schonfeld Strategic Advisors
New York
-$961K
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
76
California State Teachers Retirement System (CalSTRS)
California
$9.91K +$11K +3,657 New
AB
77
Amalgamated Bank
New York
$5K +$6.01K +2,002 New
SCM
78
Sterling Capital Management
North Carolina
$4.05K +$4.48K +1,493 New
AA
79
Addison Advisors
Vermont
$3.52K – – –
AAS
80
Ameritas Advisory Services
Nebraska
$2.71K +$3K +1,000 New
Raymond James Financial
81
Raymond James Financial
Florida
$1.63K +$1.8K +600 New
SS
82
SBI Securities
Japan
$390 +$420 +140 +3,500%
Fidelity Investments
83
Fidelity Investments
Massachusetts
$184 +$153 +51 +300%
Group One Trading
84
Group One Trading
Illinois
$54 -$1.71K -571 -97%
TRCT
85
Tower Research Capital (TRC)
New York
$8 -$37.4K -12,475 -100%
Jane Street
86
Jane Street
New York
– -$761K -224,600 Closed
Wellington Management Group
87
Wellington Management Group
Massachusetts
– -$639K -188,485 Closed
Qube Research & Technologies (QRT)
88
Qube Research & Technologies (QRT)
United Kingdom
– -$596K -175,891 Closed
HF
89
HRT Financial
New York
– -$384K -113,275 Closed
EI
90
EAM Investors
California
– -$371K -109,555 Closed
AI
91
Allostery Investments
Connecticut
– -$339K -100,000 Closed
JG
92
Jain Global
New York
– -$228K -67,212 Closed
Balyasny Asset Management
93
Balyasny Asset Management
Illinois
– -$209K -61,520 Closed
OAC
94
OMERS Administration Corp
Ontario, Canada
– -$192K -56,500 Closed
AA
95
ALPS Advisors
Colorado
– -$151K -44,436 Closed
LP
96
LMR Partners
United Kingdom
– -$128K -37,783 Closed
JFG
97
Jefferies Financial Group
New York
– -$74.6K -22,000 Closed
ECM
98
ExodusPoint Capital Management
New York
– -$74K -21,733 Closed
Wolverine Trading
99
Wolverine Trading
Illinois
– -$71.5K -21,342 Closed
QC
100
Quantessence Capital
New York
– -$56K -16,523 Closed
1 2 3
4
5

ELDN Hedge Fund Activity: Q2 2025 in Review

85 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q2 2025, worth a combined $111M — down 15% from $130M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ELDN positions and 26 closed out — a net gain of 2 holders — while 21 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $7.81M. The largest seller was Millennium Management, cutting an estimated $1.92M.

  • 85 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q2 2025, up from 83 in Q1 2025.
  • Funds reported $111M of Eledon Pharmaceuticals stock for Q2 2025, down 15% quarter-over-quarter.
  • 28 funds opened new Eledon Pharmaceuticals positions in Q2 2025 and 26 closed out, a net change of +2 holders.
  • The largest Eledon Pharmaceuticals buyer in Q2 2025 was BlackRock, an estimated $7.81M added.
  • The largest Eledon Pharmaceuticals seller in Q2 2025 was Millennium Management, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2025.